T

hree weeks after Hurricane Maria struck Puerto Rico, little is known about the extent to which the storm will affect production and supply of prescription drugs. Other than saying recovery will take time, most large drug makers have disclosed little to nothing about the status of their facilities.

However, we have obtained an internal document showing the status of seven Johnson & Johnson (JNJ) production facilities encompassing about 1.5 million square feet that were affected. And as one might expect, the situation is uncertain. All but one of the plants is open, thanks to generators, but connectivity remains an issue and so production will vary considerably from location to location.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy